Skip to main content
OpenTrials
Completed

NCT Number: NCT01995994

Continuous Glucose Monitoring System in Intensive Care Unit

To assess the accuracy, safety, and influence of sampling site of Real-time continuous glucose monitoring system (Medtronic Guardian).

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Seoul National University Hospital

Seoul, 110-744, South Korea

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Older than 18 years old
  • Staying in intensive care units longer than 72 hours

Exclusion criteria

  • Skin disease
  • DIC
  • Immune suppressed patients

Treatment and study plan

Primary outcomes

  1. Difference between finger stick blood glucose and real-time continuous glucose monitoring

    Time frame: 72 hours

Secondary outcomes

  1. Measurement error of real-time continuous glucose monitoring

    Time frame: 72 hours

Sponsors and collaborators

Lead sponsor

Seoul National University Hospital

Other

Registry information

Official study title

Continuous Glucose Monitoring System in Intensive Care Unit - Preliminary Study Evaluating Accuracy

Important dates

Study start
2012
Primary completion
2013
Study completion
2014
First posted
Nov 27, 2013
Registry last updated
May 21, 2015

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.